A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

NCT00717938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: cisplatinum or carboplatin and e.g.etoposide.
DRUG: cisplatinum or carboplatin and e.g.etoposide+enoxaparin

Sponsor

Lund University Hospital

Collaborators

[object Object]